Home › Funds › Klingman & Associates, LLC › IBDX

Klingman & Associates, LLC position in IBDX

ISHARES TR

Klingman & Associates, LLC reported holding 1,335,882 shares of IBDX (ISHARES TR) in its Q3 2026 13F filing — a position valued at US$32.2M, representing 1.34% of its reported portfolio and ranking #20 among its reported holdings. Klingman & Associates, LLC has disclosed IBDX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)1.34M sh
Reported value held$32.15M
Portfolio Weight1.34%
First reportedQ1 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Klingman & Associates, LLC's IBDX position evolved

Klingman & Associates, LLC first disclosed a stake in IBDX in Q1 2025 at 393,449 shares (US$9.8M). The position peaked in Q3 2026 at 1,335,882 shares, worth US$32.2M. Across 7 filings, Klingman & Associates, LLC increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,335,882 shares valued at US$32.2M — an increase of 160,436 shares quarter over quarter.. Notable position changes include a 31% increase in Q2 2025 (shares rose 1% over the following quarter), a 31% increase in Q3 2025 (shares were roughly flat over the following quarter), a 31% increase in Q4 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 393.45K $9.83M New
Q2 2025 514.09K $13.00M Add
Q3 2025 675.19K $17.30M Add
Q4 2025 886.73K $22.64M Add
Q1 2026 1.08M $27.33M Add
Q2 2026 1.18M $29.61M Add
Q3 2026 1.34M $32.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBDX and 13F data

IBDX (ISHARES TR) is a company whose sector is not yet classified in our data. 35 other funds we track also report a position in IBDX — the largest reported positions include Aptus Capital Advisors, LLC (US$152.0M), Capital Investment Advisors, LLC (US$88.2M), CAPITAL ADVISORS INC/OK (US$71.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBDX

All IBDX fund holders →

FAQ

How long has Klingman & Associates, LLC held IBDX?

Klingman & Associates, LLC has disclosed IBDX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Klingman & Associates, LLC's current position in IBDX?

As of Q3 2026, Klingman & Associates, LLC holds 1.34M shares of IBDX (ISHARES TR), valued at $32.15M, representing 1.34% of its reported portfolio and ranking #20.

Has Klingman & Associates, LLC been buying or selling IBDX?

In the latest 13F filing (Q3 2026), Klingman & Associates, LLC increased its position in IBDX. The position peaked in Q3 2026 at 1.34M shares.

Which other funds hold IBDX?

Other major institutional holders of IBDX include Aptus Capital Advisors, LLC, Capital Investment Advisors, LLC, CAPITAL ADVISORS INC/OK, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.